Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-10 Sale | 2024-10-15 1:45 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $8.0991 | $40,496 | 244,350 (Direct) | View |
2024-09-10 Sale | 2024-09-11 5:17 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $10.65 | $53,274 | 249,350 (Direct) | View |
2024-08-12 Sale | 2024-08-13 6:34 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $11.53 | $57,635 | 254,350 (Direct) | View |
2024-07-10 Sale | 2024-07-12 4:55 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 55,000 | $16.79 | $923,388 | 259,350 (Direct) | View |
2024-06-10 Sale | 2024-06-12 5:00 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $17.65 | $88,264 | 314,350 (Direct) | View |
2024-05-13 Sale | 2024-05-14 4:04 pm | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $13.22 | $66,093 | 319,350 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-10 Exercise | 2024-10-15 1:45 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $0 | 244,350 (Direct) | View |
2024-10-10 Exercise | 2024-10-15 1:45 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 244,350 (Direct) | View |
2024-09-10 Exercise | 2024-09-11 5:17 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $0 | 249,350 (Direct) | View |
2024-09-10 Exercise | 2024-09-11 5:17 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 249,350 (Direct) | View |
2024-08-12 Exercise | 2024-08-13 6:34 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $0 | 254,350 (Direct) | View |
2024-08-12 Exercise | 2024-08-13 6:34 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 254,350 (Direct) | View |
2024-07-10 Exercise | 2024-07-12 4:55 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $0 | 259,350 (Direct) | View |
2024-07-10 Exercise | 2024-07-12 4:55 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 259,350 (Direct) | View |
2024-06-10 Exercise | 2024-06-12 5:00 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $0 | 314,350 (Direct) | View |
2024-06-10 Exercise | 2024-06-12 5:00 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 314,350 (Direct) | View |
2024-05-13 Exercise | 2024-05-14 4:04 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 5,000 | $2.33 | 319,350 (Direct) | View |
2024-01-05 Option Award | 2024-01-09 6:52 pm | N/A 2034-01-04 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 306,250 | $0 | 433,195 (Direct) | View |
Ownership | 2023-11-02 9:42 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 0 | $0 | 906,222 (Direct) | View |